BOSTON DR LIM

BIOTECH (130) Atlas Ventures: Option-to-Buy M&A Model – Nimbus Discovery & IFM Therapeutics

March 13, 2024March 13, 2024

부러우면 지는거다 (33) 편정현 헤드헌터 – 자리잡자

March 13, 2024July 6, 2025

BIOTECH (129) VLP Therapeutics: Self-Amplifying mRNA in Virus-Like Particle

March 12, 2024March 13, 2024

부러우면 지는거다 (32) Elie Dolgin, Ph.D. – Science Journalist

March 12, 2024March 12, 2024

BIOTECH (128) Calithera Biosciences의 실패에 대한 소고

March 12, 2024March 12, 2024

BIOTECH (127) Kenai Therapeutics: Allogeneic iPSC-Induced Neurology Cell Therapy

March 12, 2024March 12, 2024

BIOTECH (126) Accent Therapeutics: Small Molecules Targeting RNA-Modifying Protein

March 11, 2024March 11, 2024

BIOTECH (125) Bicycle Therapeutics: Bispecific Bicyclic Peptides Platform

March 11, 2024March 11, 2024

BOSTONIAN (40) 막내딸의 믿음

March 11, 2024

내가 쓰는 나의 삶 (37) 김경록 박사의 생애자산관리 두 퍼즐: 주식시장 참여 퍼즐과 연금 퍼즐

March 10, 2024October 16, 2025